A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors
BeOne Medicines
BeOne Medicines
Seagen Inc.
Eli Lilly and Company
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
Travera Inc
Eli Lilly and Company
National Cancer Institute (NCI)
IDEAYA Biosciences
OncoC4, Inc.
AstraZeneca
Memorial Sloan Kettering Cancer Center
Alliance for Clinical Trials in Oncology
Pfizer
IDEAYA Biosciences
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Aulos Bioscience, Inc.
Arcus Biosciences, Inc.
AstraZeneca
Memorial Sloan Kettering Cancer Center
Sotio Biotech Inc.
National Institutes of Health Clinical Center (CC)
Pfizer
Rondo Therapeutics
M.D. Anderson Cancer Center
Origin Sciences
M.D. Anderson Cancer Center
UMC Utrecht
Memorial Sloan Kettering Cancer Center
ViroMissile, Inc.
AstraZeneca
Tizona Therapeutics, Inc
Tasca Therapeutics
Essen Biotech
Azienda Ospedaliero-Universitaria di Parma
Clasp Therapeutics, Inc.
Baylor College of Medicine
University of Colorado, Denver
MacroGenics
Institut Bergonié
City of Hope Medical Center
xCures
Daiichi Sankyo
University of Nebraska
Boehringer Ingelheim
Adela, Inc
Second Life Therapeutics
Ocellaris Pharma, Inc.
Medical College of Wisconsin